Company news
Profound Medical Corp news in 2025
Profound Medical Corp's news releases, calls and decks from 2025, newest first.
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
Profound Medical Corp. Announces Upsize of Private Placement
December 24, 2025
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
December 23, 2025
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
December 19, 2025
Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 4, 2025
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
November 11, 2025
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
November 10, 2025
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
October 16, 2025
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
October 14, 2025
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
October 7, 2025
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
September 23, 2025
Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference
August 28, 2025
Profound Medical Announces Second Quarter 2025 Financial Results
August 14, 2025
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 - Conference Call to Follow
July 24, 2025
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
June 10, 2025
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
June 4, 2025
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
May 14, 2025
Profound Medical Announces First Quarter 2025 Financial Results
May 8, 2025
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2025
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
April 29, 2025
Profound Medical to Release First Quarter 2025 Financial Results on May 8 - Conference Call to Follow
April 17, 2025
Profound Medical AUA 2025 Investor Event Agenda
April 15, 2025
Save the Date: Profound Medical to Host Investor Event at AUA 2025
March 25, 2025
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
March 6, 2025
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 - Conference Call to Follow
February 13, 2025
Calls in 2025
Decks in 2025
- Investor Presentation (November 2025)
Investor deck · 32 slides · November 2025
- Investor Presentation (November 2025)
Investor deck · 31 slides · November 2025
- AUA 2025 Investor Event
Conference · 88 slides · Apr 29, 2025